BliNK Biomedical
Latest round
- Series A
Last raised
- Feb 2015
Total raised
- $17M
Investors
- 3
About BliNK Biomedical
Founded in 2015, BliNK Biomedical SAS operates from Lyon, France, focusing on antibody discovery solutions. The company has undergone no major pivots and is not known to have subsidiaries. The founder's history is not available.BliNK Biomedical specializes in advanced B cell technology that allows for the selection and isolation of specific antibody-producing cells targeted toward challenging antigens. Their core product offerings leverage sophisticated platforms, namely ISAAC and VIVA|Screen, which facilitate a highly efficient mining process to identify rare antibody-secreting cells across various species, including humans, mice, rabbits, and dogs. The technology is designed to meet the needs of biopharmaceutical companies and research institutions that require unique therapeutic antibodies for the development of innovative treatments. BliNK Biomedical serves a global client base, focusing primarily on North America, Europe, and parts of Asia, where there is a significant demand for bespoke biologic therapies.10 in 2023, with an EBITDA of EUR 377,824. The company primarily engages in business-to-business transactions with pharmaceutical companies and research organizations that utilize their antibody selection technology. Various partnerships may involve licensing agreements for their proprietary platforms, enabling access to advanced technology for antibody discovery. Each transaction typically encompasses an initial setup fee for technology integration, followed by recurring payments based on the identification of therapeutic candidates. The company is focused on introducing new products aimed at enhancing its antibody selection technology, targeting a broader client base in North America and Europe by 2025.
Who invested in BliNK Biomedical
3 investors across 1 round
See all investors in BliNK Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 26, 2015
Amount
$17M
Investors
Questions about BliNK Biomedical
Who invested in BliNK Biomedical?
BliNK Biomedical has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BliNK Biomedical raised?
BliNK Biomedical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BliNK Biomedical last raise money?
BliNK Biomedical's most recent round on record is a Series A, in Feb 2015.
What does BliNK Biomedical do?
Founded in 2015, BliNK Biomedical SAS operates from Lyon, France, focusing on antibody discovery solutions.
Where is BliNK Biomedical headquartered?
BliNK Biomedical is headquartered in Lyon, France.
Which VCs invest in companies like BliNK Biomedical?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at BliNK Biomedical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BliNK Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.